Skip To Main Content
Bar Nathansohn-Levi on Muck Rack

Bar Nathansohn-Levi

As seen in: Texas Medical Center
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bar

Contact Bar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

"Correction of T-Cell Repertoire and Autoimmune Diabetes in NOD Mice by" by Rakefet Sidlik Muskatel, Bar Nathansohn-Levi et al.

|
By Shlomit Reich-Zeliger, Michal Mark, Rakefet Sidlik Muskatel, Bar Nathansohn-Levi
| Texas Medical Center
Abstract The induction of partial tolerance toward pancreatic autoantigens in the treatment of type 1 diabetes mellitus (T1DM) can be attained by autologous hematopoietic stem cell transplantation (HSCT). However, most patients treated by autologous HSCT eventually relapse. Furthermore, allogeneic HSCT which could potentially provide a durable non-autoimmune T-cell receptor (TCR) repertoire is associated with a substantial risk for transplant-related mortality.
Open in Who Shared Issue with article?
See all 1 articles